Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03548285 · ClinicalTrials.gov registry record · NA
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03548285 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT03548285, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a prospective study to determine the local control and quality-of-life outcomes of using SBRT for early-stage glottic larynx cancer.
Interventions
- RADIATION Radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-05-15 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03548285
The ClinicalTrials.gov registry entry for NCT03548285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiation therapy is the first listed.
NCT03548285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03548285 about?
NCT03548285 is a clinical study titled "Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer". This is a prospective study to determine the local control and quality-of-life outcomes of using SBRT for early-stage glottic larynx cancer.
What is the current status of trial NCT03548285?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-05-15. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT03548285?
The interventions under investigation include: Radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT03548285?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.